Protiva Biotherapeutics
Latest round
- Series D
Last raised
- Jul 2007
Total raised
- $8.3M
Investors
- 4
About Protiva Biotherapeutics
Protiva Biotherapeutics is a US-based biotechnology company that operates as a developer of nucleic acid based pharmaceutical products.
Who invested in Protiva Biotherapeutics
4 investors across 2 rounds
See all investors in Protiva Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Protiva Biotherapeutics
Who invested in Protiva Biotherapeutics?
Protiva Biotherapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Protiva Biotherapeutics raised?
Protiva Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Protiva Biotherapeutics last raise money?
Protiva Biotherapeutics's most recent round on record is a Series D, in Jul 2007.
What does Protiva Biotherapeutics do?
Protiva Biotherapeutics is a US-based biotechnology company that operates as a developer of nucleic acid based pharmaceutical products.
Where is Protiva Biotherapeutics headquartered?
Protiva Biotherapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Protiva Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Protiva Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Protiva Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.